Author
Listed:
- Elga Esposito
(Harvard Medical School)
- Wenlu Li
(Harvard Medical School)
- Emiri T. Mandeville
(Harvard Medical School)
- Ji-Hyun Park
(Harvard Medical School
Seoul National University)
- Ikbal Şencan
(Harvard Medical School)
- Shuzhen Guo
(Harvard Medical School)
- Jingfei Shi
(Harvard Medical School
Capital Medical University)
- Jing Lan
(Harvard Medical School
Capital Medical University)
- Janice Lee
(Harvard Medical School)
- Kazuhide Hayakawa
(Harvard Medical School)
- Sava Sakadžić
(Harvard Medical School)
- Xunming Ji
(Capital Medical University)
- Eng H. Lo
(Harvard Medical School)
Abstract
Neuroprotectant strategies that have worked in rodent models of stroke have failed to provide protection in clinical trials. Here we show that the opposite circadian cycles in nocturnal rodents versus diurnal humans1,2 may contribute to this failure in translation. We tested three independent neuroprotective approaches—normobaric hyperoxia, the free radical scavenger α-phenyl-butyl-tert-nitrone (αPBN), and the N-methyl-d-aspartic acid (NMDA) antagonist MK801—in mouse and rat models of focal cerebral ischaemia. All three treatments reduced infarction in day-time (inactive phase) rodent models of stroke, but not in night-time (active phase) rodent models of stroke, which match the phase (active, day-time) during which most strokes occur in clinical trials. Laser-speckle imaging showed that the penumbra of cerebral ischaemia was narrower in the active-phase mouse model than in the inactive-phase model. The smaller penumbra was associated with a lower density of terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL)-positive dying cells and reduced infarct growth from 12 to 72 h. When we induced circadian-like cycles in primary mouse neurons, deprivation of oxygen and glucose triggered a smaller release of glutamate and reactive oxygen species, as well as lower activation of apoptotic and necroptotic mediators, in ‘active-phase’ than in ‘inactive-phase’ rodent neurons. αPBN and MK801 reduced neuronal death only in ‘inactive-phase’ neurons. These findings suggest that the influence of circadian rhythm on neuroprotection must be considered for translational studies in stroke and central nervous system diseases.
Suggested Citation
Elga Esposito & Wenlu Li & Emiri T. Mandeville & Ji-Hyun Park & Ikbal Şencan & Shuzhen Guo & Jingfei Shi & Jing Lan & Janice Lee & Kazuhide Hayakawa & Sava Sakadžić & Xunming Ji & Eng H. Lo, 2020.
"Potential circadian effects on translational failure for neuroprotection,"
Nature, Nature, vol. 582(7812), pages 395-398, June.
Handle:
RePEc:nat:nature:v:582:y:2020:i:7812:d:10.1038_s41586-020-2348-z
DOI: 10.1038/s41586-020-2348-z
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Jiayi Wang & Mengke Zhao & Meina Wang & Dong Fu & Lin Kang & Yu Xu & Liming Shen & Shilin Jin & Liang Wang & Jing Liu, 2024.
"Human neural stem cell-derived artificial organelles to improve oxidative phosphorylation,"
Nature Communications, Nature, vol. 15(1), pages 1-24, December.
- Dalia Halawani & Yiqun Wang & Aarthi Ramakrishnan & Molly Estill & Xijing He & Li Shen & Roland H. Friedel & Hongyan Zou, 2023.
"Circadian clock regulator Bmal1 gates axon regeneration via Tet3 epigenetics in mouse sensory neurons,"
Nature Communications, Nature, vol. 14(1), pages 1-22, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:582:y:2020:i:7812:d:10.1038_s41586-020-2348-z. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.